Paragon 28 Conducts the First Total Ankle Joint Replacement Surgery Utilizing Laser Alignment Technology

Paragon 28, Inc. continues to revolutionize the Orthopedic Total Ankle Joint Replacement (TAR) market by successfully introducing the FasTrac Distal Tibia Alignment System, featuring proprietary laser technology developed to provide a precise visual reference point during component alignment, a critical step in establishing optimal implant placement during TAR procedures.

Abnormal alignment of an implant construct is reported to be a major cause of implant loosening and decreased postoperative function. The FasTrac Distal Tibia Alignment System addresses the importance of implant orientation by utilizing the first and only laser alignment verification technology to ultimately guide the surgeon to the desired position.

Dr. Jason Nowak performed the first surgery with Paragon 28’s laser technology in Redding California last week and stated:

“In addition to expediting and visually enhancing alignment, the System streamlines the surgical technique by eliminating the need to insert an additional pin into the tibial tubercle or conducting CT scans that may be necessary for other total ankle alignment techniques.”

FasTrac is the third alignment system offered for the APEX 3D Total Ankle, complementing MAVEN PSI and the Traditional Alignment Guide. Learn more about the FasTrac Distal Tibia Alignment System with Laser Technology here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”